ArticleJournal for immunotherapy of cancer2021

Pathways of immune exclusion in metastatic osteosarcoma are associated with inferior patient outcomes.

John A Ligon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.